UK pharmaceutical companies aim to put executive pay on par with US rivals’ but package will depend on share price

GSK’s chief executive could take home nearly £22m this year as the pharmaceutical company attempts to offer US-style pay packets to top executives.

Emma Walmsley’s pay package will reach a maximum of £21.56m if the company’s share price rises by 50%, according to its annual report. That includes fixed pay of £1.7m. A package of £16.4m looks more realistic, which would still represent a hefty pay rise.

Continue reading...